Glaukos planned sale of 525 restricted shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Glaukos Corporation has a notice of proposed sale under Form 144 by Leana Wen covering 525 shares of common stock, with an aggregate market value of $88,005.75, expected around July 31, 2026. These shares stem from restricted stock vesting on May 30, 2025 and are classified as compensation. Over the prior three months, Wen sold 1,700 common shares on May 1, 2026 for an aggregate value of $247,095.17.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Vesting financial
aggregate market value financial
Compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Glaukos (GKOS) disclose in this Form 144 filing?
What Glaukos (GKOS) stock sales occurred in the past three months for this filer?
Who is the reporting person in this Glaukos (GKOS) Form 144 and which broker is listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.